Valicenti Advisory Services Inc. Boosts Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Valicenti Advisory Services Inc. boosted its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 0.8% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 27,426 shares of the company’s stock after purchasing an additional 210 shares during the period. Valicenti Advisory Services Inc.’s holdings in GE HealthCare Technologies were worth $2,574,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Wellington Management Group LLP lifted its position in shares of GE HealthCare Technologies by 575.6% during the fourth quarter. Wellington Management Group LLP now owns 21,118 shares of the company’s stock worth $1,633,000 after acquiring an additional 17,992 shares in the last quarter. Park Avenue Securities LLC purchased a new stake in shares of GE HealthCare Technologies during the first quarter worth $227,000. Wealthcare Advisory Partners LLC purchased a new stake in shares of GE HealthCare Technologies during the first quarter worth $255,000. Wealth Enhancement Advisory Services LLC lifted its position in shares of GE HealthCare Technologies by 0.9% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 197,493 shares of the company’s stock worth $17,954,000 after acquiring an additional 1,817 shares in the last quarter. Finally, Artemis Investment Management LLP lifted its position in shares of GE HealthCare Technologies by 23.6% during the first quarter. Artemis Investment Management LLP now owns 112,004 shares of the company’s stock worth $10,177,000 after acquiring an additional 21,401 shares in the last quarter. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 0.4 %

NASDAQ GEHC opened at $88.90 on Friday. The stock’s 50-day simple moving average is $88.35 and its two-hundred day simple moving average is $83.45. GE HealthCare Technologies Inc. has a twelve month low of $62.35 and a twelve month high of $94.55. The company has a quick ratio of 0.82, a current ratio of 1.06 and a debt-to-equity ratio of 1.05. The company has a market capitalization of $40.58 billion, a price-to-earnings ratio of 25.99, a PEG ratio of 3.39 and a beta of 1.18.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, July 31st. The company reported $1.00 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.98 by $0.02. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The firm had revenue of $4.84 billion for the quarter, compared to analysts’ expectations of $4.88 billion. During the same period last year, the firm earned $0.92 earnings per share. The company’s revenue for the quarter was up .5% compared to the same quarter last year. Research analysts forecast that GE HealthCare Technologies Inc. will post 4.26 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a dividend of $0.03 per share. The ex-dividend date of this dividend is Friday, October 18th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.13%. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.51%.

Wall Street Analysts Forecast Growth

GEHC has been the topic of several recent research reports. UBS Group downgraded GE HealthCare Technologies from a “neutral” rating to a “sell” rating and dropped their target price for the stock from $84.00 to $74.00 in a research report on Thursday, September 26th. BTIG Research upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 target price on the stock in a research report on Wednesday, September 18th. Stifel Nicolaus increased their price objective on GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a “buy” rating in a research report on Monday, September 30th. Evercore ISI increased their price objective on GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 1st. Finally, Redburn Atlantic upgraded GE HealthCare Technologies to a “strong-buy” rating in a research report on Thursday, August 1st. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, seven have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and a consensus price target of $94.23.

Insider Activity

In other news, CEO Thomas J. Westrick sold 2,750 shares of the firm’s stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total transaction of $222,145.00. Following the transaction, the chief executive officer now directly owns 17,509 shares of the company’s stock, valued at approximately $1,414,377.02. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.27% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.